Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer |
|
https://doi.org/10.18632/oncotarget.27763
Konrad Klinghammer,
Oliver Politz,
Theresa Eder,
Raik Otto,
Jan-Dirk Raguse,
Andreas Albers,
Andreas Kaufmann,
Ingeborg Tinhofer,
Jens Hoffmann,
Ulrich Keller,
and Ulrich Keilholz
|
| 3688-3697 |
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo |
|
https://doi.org/10.18632/oncotarget.27726
Tiziano Ongaro,
Baptiste Gouyou,
Marco Stringhini,
Riccardo Corbellari,
Dario Neri,
and Alessandra Villa
|
| 3698-3711 |
Evaluation of cancer-derived myocardial impairments using a mouse model
Evaluation of cancer-derived myocardial impairments using a mouse model |
|
https://doi.org/10.18632/oncotarget.27759
Yoshihiro Miyagawa,
Shota Nukaga,
Takuya Mori,
Rina Fujiwara-Tani,
Kiyomu Fujii,
Shiori Mori,
Kei Goto,
Shingo Kishi,
Takamitsu Sasaki,
Chie Nakashima,
Hitoshi Ohmori,
Isao Kawahara,
Yi Luo,
and Hiroki Kuniyasu
|
| 3712-3722 |
Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment |
|
https://doi.org/10.18632/oncotarget.27757
Gennady M. Zharinov,
Oleg A. Bogomolov,
Irina V. Chepurnaya,
Natalia Yu. Neklasova,
and Vladimir N. Anisimov
|
| 3723-3729 |
Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis
Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis |
|
https://doi.org/10.18632/oncotarget.27750
Milena Marques Pagliarelli Acencio,
Bruna Rocha Silva,
Lisete Ribeiro Teixeira,
Vanessa Adélia Alvarenga,
Carlos Sérgio Rocha Silva,
Aline Graças Pereira da Silva,
Vera Luiza Capelozzi,
and Evaldo Marchi
|
| 3730-3736 |
Efavirenz induces DNA damage response pathway in lung cancer
Efavirenz induces DNA damage response pathway in lung cancer |
|
https://doi.org/10.18632/oncotarget.27725
Rahaba Marima,
Rodney Hull,
Zodwa Dlamini,
and Clement Penny
|
| 3737-3748 |
Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor |
|
https://doi.org/10.18632/oncotarget.27755
Suyoun Chung,
Kyoko Kijima,
Aiko Kudo,
Yoshiko Fujisawa,
Yosuke Harada,
Akiko Taira,
Naofumi Takamatsu,
Takashi Miyamoto,
Yo Matsuo,
and Yusuke Nakamura
|
| 3749-3750 |
